Preview
Unable to display preview. Download preview PDF.
References
Moreira, PL, Lansden, CC, Clark, TL. Effect of Hemopure® on prothrombin time and activated partial thromboplastin time on seven coagulation analyzers. Clin Chem 1997; 43:1792.
Mischke, R, Wolling, H. Influence of fibrinogen degradation products on thrombin time, activated partial thromboplastin time and prothrombin time of canine plasma. Haemostasis 2000; 30:123–30.
Mischke, R, Menzel, D, Wolling, H. Comparison of different methods to measure fibrinogen concentration in canine plasma with respect to their sensitivity towards the fibrinogen degradation products X, Y and D. Haemostasis 2000; 30:131–8.
Point-of-care monitoring of anticoagulation therapy; approved guideline. CLSI document H49-A.Wayne, PA: Clinical and Laboratory Standards Institute, 2004.
Murray, ET, Fitzmaurice, DA, McCahon, D. Point of care testing for INR monitoring; where are we now? BMJ 2004; 127:373–8.
Spinler, SA, Nutescu, EA, Smythe, MA. Anticoagulation monitoring part 1: warfarin and parenteral direct thrombin inhibitors. Ann Pharmacother 2005; 39:1049–55.
Yang, DT, Robetorye, R, Rodgers, GM. Home prothrombin time monitoring: a literature analysis. Am J Hematol 2004; 77:177–86.
Point-of-care connectivity; approved guideline. CLSI document POCT1-A. Wayne, PA: Clinical and Laboratory Standards Institute, 2001.
Dalbert, S, Ganter, MT, Furrer, L. Effects of heparin, haemodilution and aprotinin on kaolin-based activated clotting time: in vitro comparison of two different point of care devices. Acta Anesthesiol Scand 2006; 50:461–468.
Santrach, PJ. Point-of-care hematology, hemostasis, and thrombolysis testing. In: Kost, GJ, editor. Principals and practice of point-of-care testing. Philadelphia: Lippincott Williams & Wilkins, 2002:157–80.
Kratz, A, Van Cott, EM. Activated clotting time methods and clinical applications. Point of Care 2005; 4:90–4.
Salooja, N, Perry, DJ. Thromboelastography. Blood Coagul Fibrinolysis 2001; 12:327–37.
Khurana, S, Mattson, JC, Westley, S. Monitoring platelet glycoprotein IIb/IIIa-fibrin interaction with tissue factor-activated thromboelastography. J Lab Clin Med 1997; 130:401–11.
Mousa, SA, Khurana, S, Forsythe, MS. Comparative In Vitro efficacy of different platelet glycoprotein IIb/IIIa antagonists on platelet-mediated clot strength induced by tissue factor with use of thromboelastography: differentiation among glycoprotein IIb/IIIa antagonists. Arterioscler Thromb Vasc Biol 2000; 20:1162–67.
Waters, JH, Anthony, DG, Gottlieb, A. Bleeding in a patient receiving platelet aggregation inhibitors. Anesth Analg 2001; 93:878–82.
Horlocker, TT, Schroeder, DR. Effect of age, gender, and platelet count on Sonoclot coagulation analysis in patients undergoing orthopedic operations. Mayo Clin Proc 1997; 72:214–19.
Rodgers, RPC, Levin, J. A critical reappraisal of the bleeding time. Semin Thromb Hemost 1990; 16:1–20.
Hayward CPM, Harrison P, Cataneo TL, et al. Platelet Physiology Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Platelet function analyzer (PFA)-100® closure time in the evaluation of platelet disorders and platelet function. J Thromb Haemost 2006; 4:312–19.
Hayward, CPM, Harrison, P, Cattaneo, M, et al. Platelet function analyzer (PFA)-100® closure time in the evaluation of platelet disorders and platelet function. J Thromb Haemost 2006; 4:312–19.
Harrison, P. The role of PFA-100® testing in the investigation and management of haemostatic defects in children and adults. Br J Haematol 2005; 130:3–10.
Haubelt, H, Anders, Christof, Vogt, Anette, et al. Variables influencing platelet function analyzer-100™ closure times in healthy individuals. Br J Haematol 2005; 130:759–67.
Prisco, D, Paniccia, R. Point-of-care testing of hemostasis in cardiac surgery. Thromb J 2003; 1:1–10.
Despotis, GJ, Joist, JH, Goodnough, LT. Monitoring of hemostasis in cardiac surgical patients: impact of point-of-care testing on blood loss and transfusion outcomes. Clin Chem 1997; 43:1684–96.
Carr, ME. Development of platelet contractile force as a research and clinical measure of platelet function. Cell Biochem Biophy 2003; 38:55–78.
Editor information
Rights and permissions
Copyright information
© 2007 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Lehman, C.M., Thompson, C. (2007). Instrumentation for the Coagulation Laboratory. In: Thompson, C., Blaylock, R.C. (eds) Laboratory Hemostasis. Springer, Boston, MA. https://doi.org/10.1007/0-387-36840-X_3
Download citation
DOI: https://doi.org/10.1007/0-387-36840-X_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-36838-2
Online ISBN: 978-0-387-36840-5
eBook Packages: MedicineMedicine (R0)